Medical Properties Trust Reports $0.34 EPS and $0.11 NFFO Per Share
Medical Properties Trust reported Q3 2026 net income of $202M ($0.34 EPS), up from a $78M loss last year. NFFO was $64M ($0.11 EPS), down from $77M ($0.13 EPS) year-over-year. Revenue rose to $250.1M from $237.5M. The company completed asset sales and a $2.4B secured-notes offering to strengthen its balance sheet. It sold hospital interests for $680M and paid a $0.09 dividend.
How this was made
The 30-second read
Why it matters
Q3 2026 shows higher net income year over year, but lower NFFO per share, alongside a large secured-notes issuance and hospital interest sales. The refinancing and dispositions may reduce near-term debt pressure, while revenue-cycle/billing issues could affect cash flow quality.
Market read
Traders can reassess near-term leverage trajectory and cash-flow durability using the disclosed refinancing, disposition proceeds, and the NFFO per-share decline.
What to watch
The article flags September rent payment prevention due to revenue-cycle challenges and ongoing monitoring of HSA operations, which could pressure future cash collections even after refinancing.
Background
The company is a healthcare REIT with hospital-related assets and uses asset sales and secured debt to strengthen its balance sheet.
Ticker impact
Medical Properties Trust reported Q3 2026 EPS of $0.34 and NFFO of $0.11, plus a $2.4B secured-notes offering and major hospital asset sales.
Likely mixed reaction, with support from higher net income and refinancing proceeds, offset by weaker NFFO per share and ongoing revenue-cycle challenges.
The article provides both an earnings datapoint (EPS, NFFO) and concrete capital-structure actions (secured notes, debt repayment) plus asset-sale proceeds, which together can drive a two-sided valuation read-through.
Market effects
Highlights ongoing REIT balance-sheet management via secured debt and hospital-asset monetization, relevant to healthcare REIT peers’ leverage and disposition expectations.
No specific regional macro linkage beyond hospital operations across nine countries.
Limited; the portfolio is international but the disclosed catalysts are company-specific refinancing and asset sales.
Counterpoint
Investors may discount the net income improvement because NFFO per share fell and the quarter included large gains from real estate sales and refinancing benefits that may not recur.
Key entities
- companyMedical Properties Trust, Inc.
Reported Q3 2026 EPS and NFFO, completed a $2.4B secured-notes offering, and sold hospital interests while monitoring HSA revenue-cycle operations.
